Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: Results of the randomized phase 3 CADMUS study

Autor: Landells, Ian, Marano, Colleen, Hsu, Ming-Chun, Li, Shu, Zhu, Yaowei, Eichenfield, Lawrence F., Hoeger, Peter H., Menter, Alan, Paller, Amy S., Taieb, Alain, Philipp, Sandra, Szapary, Philippe, Randazzo, Bruce
Zdroj: In Journal of the American Academy of Dermatology October 2015 73(4):594-603
Databáze: ScienceDirect